Skip to main content

Peer Review reports

From: HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy

Original Submission
12 Mar 2009 Submitted Original manuscript
1 May 2009 Reviewed Reviewer Report - A Serrano-Olvera
10 May 2009 Reviewed Reviewer Report - Adelaida Garcia-Velasco
10 May 2009 Reviewed Reviewer Report - Karina Dahl Steffensen
11 Jul 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 2
11 Jul 2009 Submitted Manuscript version 2
3 Aug 2009 Reviewed Reviewer Report - Adelaida Garcia-Velasco
12 Aug 2009 Reviewed Reviewer Report - Karina Dahl Steffensen
Resubmission - Version 3
Submitted Manuscript version 3
1 Oct 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 4
1 Oct 2009 Submitted Manuscript version 4
4 Nov 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 5
4 Nov 2009 Submitted Manuscript version 5
1 Dec 2009 Author responded Author comments - Jessica N. McAlpine
Resubmission - Version 6
1 Dec 2009 Submitted Manuscript version 6
Publishing
10 Dec 2009 Editorially accepted
10 Dec 2009 Article published 10.1186/1471-2407-9-433

You can find further information about peer review here.

Back to article page